marijuana stock news

Primco Management Inc. (PMCM)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue –   46   45   12  
Cost of Revenue 44 6 24 0
Gross Profit (44) 40   21   12  
Operating Expenses
Research Development
Selling General and Administrative 401 372 307 237
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (445) (332) (285) (226)
Income from Continuing Operations
Total Other Income/Expenses Net 30
Earnings Before Interest And Taxes (415) (332) (285) (226)
Interest Expense (4,431) 9,146 2,901 196
Income Before Tax 4,016 (9,478) (3,186) (422)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops 4,046 (9,478) (3,186) (422)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 4,016   (9,478) (3,186) (422)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares 4,016   (9,478) (3,186) (422)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AbbVie (ABBV) Submits Supplemental New Drug Application to U.S. FDA

AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New…

AbbVie (ABBV) Vice Chairman of External Affairs and Chief Legal Officer Laura J. Schumacher to Retire

AbbVie Vice Chairman of External Affairs and Chief Legal Officer Laura J.…

1933 Industries Inc. (TGIFF) (TGIF) Brings the Iconic Jack Herer Brand to Nevada

1933 Industries Brings the Iconic Jack Herer Brand to Nevada 1933 Industries…

Therapeutics, Inc. (INSY) Releases Statement on Illinois Settlement

Corporate News Blog – Insys Therapeutics Releases Statement on Illinois Settlement; Provides…